Most Zepbound side effects are digestive. Nausea, diarrhea, constipation, vomiting, reflux, and stomach pain are the pattern people notice first, especially after a dose increase. The goal is not to ignore them. The goal is to know what is normal, what improves, and what needs a clinician now.
🔑 Key Takeaways
- The main keyword for this article is Zepbound side effects, and the dominant SERP intent is practical triage: common symptoms, timeline, and when to call a doctor.
- The most common Zepbound side effects are nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, allergic-type reactions, burping, hair loss, and reflux.
- Symptoms usually cluster around starting Zepbound or increasing the dose. Holding a dose longer can be more useful than pushing upward on schedule.
- Red flags include severe or lasting stomach pain, repeated vomiting, dehydration, trouble breathing, swelling of the face or throat, vision changes, and symptoms of low blood sugar if you use insulin or a sulfonylurea.
- Zepbound is also indicated for moderate to severe obstructive sleep apnea in adults with obesity, so some readers are taking it for sleep apnea as well as weight loss.
Zepbound Side Effects at a Glance
Start with the pattern first. Most Zepbound side effects come from slower stomach emptying, lower appetite, and the dose-escalation process.
One framing note before the symptoms. Zepbound is FDA approved for adults with obesity, or with overweight plus at least one weight-related condition such as high blood pressure or type 2 diabetes, and for moderate to severe obstructive sleep apnea in adults with obesity. The same active ingredient, tirzepatide, is also sold as Mounjaro for type 2 diabetes, so the two share a side-effect profile. The low-blood-sugar and diabetic-eye cautions further down mostly matter for people who also have type 2 diabetes. See the FDA Zepbound prescribing information for the approved use.
Zepbound Side Effects Week by Week
The first weeks teach you tolerance. A lot of people expect the first shot to be the hardest, but the bigger test is usually the first move from 2.5 mg to 5 mg.
Dose-escalation rule
Zepbound starts at 2.5 mg once weekly for 4 weeks. The dose can rise in 2.5 mg steps after at least 4 weeks, but tolerability matters more than speed. If side effects are heavy, staying longer at the current dose is often the cleaner conversation to have with your prescriber.
How to Manage Zepbound Nausea
Nausea responds to meal size. The mistake is eating the same plate you ate before Zepbound and expecting your stomach to move it at the same speed.
- Eat half portions, then wait 15 minutes before adding more.
- Keep protein easy: Greek yogurt, eggs, lean meat, cottage cheese, or a simple shake.
- Go lower fat during the first few days after each dose increase.
- Skip alcohol when nausea, reflux, or dehydration is active.
- Stop eating when fullness starts, not when the plate is empty.
- Ask your prescriber about anti-nausea medication if symptoms are interfering with hydration.
Constipation, Diarrhea, and Reflux
Gut symptoms need opposite fixes. Diarrhea needs fluid and electrolytes first; constipation needs slow fiber, movement, and enough water to make the fiber useful.
Serious Zepbound Side Effects
Rare symptoms deserve fast action. Call your prescriber or seek urgent care if the symptom feels severe, sudden, or different from typical nausea.
Diabetic retinopathy. If you also have type 2 diabetes, a quick drop in blood sugar after starting Zepbound can briefly worsen diabetic retinopathy, the eye-vessel damage that long-term high blood sugar causes. This is tied to how fast blood sugar improves rather than to Zepbound itself, and anyone with a history of retinopathy should have their eyes checked on a schedule. Report new blurry vision, floaters, or vision loss to the clinician managing your diabetes. See the FDA Zepbound prescribing information for the labeled vision warning.
Zepbound and Sleep Apnea Side Effects
The side-effect profile is similar. Zepbound now appears in search results for weight loss and obstructive sleep apnea because the FDA label includes moderate to severe OSA in adults with obesity.
That does not make side effects different, but it does change the reader. If you are using Zepbound for sleep apnea, keep your sleep clinician in the loop before changing CPAP, oral appliance use, or other sleep-apnea treatment. Weight loss can improve breathing, but your airway plan should change only with follow-up testing or clinician guidance.
Zepbound vs Wegovy Side Effects
The overlap is large. Both medications can cause nausea, vomiting, diarrhea, constipation, reflux, gallbladder issues, and dehydration problems.
The practical difference is mechanism and dose response. Zepbound is tirzepatide, a GIP/GLP-1 agonist. Wegovy is semaglutide, a GLP-1 agonist. In the real world, some people tolerate one better than the other, so side effects are a valid reason to discuss switching rather than quitting the category entirely. For broader options, see our Ozempic alternatives breakdown.
When to Stop or Hold a Dose
Do not freestyle escalation. If side effects are strong enough to stop normal eating, hydration, sleep, or work, that is a signal to talk about holding the dose.
- Hold escalation if nausea is still active near the end of the 4-week step.
- Ask about stepping back if vomiting, diarrhea, or reflux is recurring.
- Seek care right away for severe abdominal pain, allergic symptoms, fainting, or dehydration.
- Tell surgical teams you use Zepbound before anesthesia or deep sedation.
Zepbound Side Effects Frequency Table
The percentages below come from the pooled SURMOUNT-1 through SURMOUNT-5 trial data and the FDA Zepbound prescribing information. They reflect events reported during the 72-week trials at any time on the drug, not the rate at any single moment. Most patients improve substantially after the first 12 weeks once dose escalation is complete.
The most useful pattern in this table is that GI side effects are common but mild, while the rare events (pancreatitis, gallbladder problems, severe vomiting requiring fluids) are the ones that warrant a medical call. See the Zepbound vs Mounjaro comparison if you are weighing which brand makes more sense given your side-effect tolerance.
What Long-Term Zepbound Safety Data Shows
Three years is the longest published safety horizon for tirzepatide in adults with obesity, drawn from the SURMOUNT-4 maintenance trial and the SURPASS-4 cardiovascular outcomes extension. The headline finding is that the side-effect profile does not get worse with time. Most GI symptoms decline after the first 6 months and stay at a low level through year three. Hair loss almost always resolves once weight stabilizes, typically by month 12.
The harder-to-quantify questions are about pancreas, kidney, and thyroid risk. Pooled tirzepatide trial data through 2025 shows no significant increase in pancreatic cancer, kidney injury, or medullary thyroid cancer compared to placebo. The thyroid boxed warning persists because rodent studies showed C-cell tumors at high doses, but human data has not replicated the signal. The FDA still excludes patients with a personal or family history of MTC or MEN-2.
Gallbladder problems are the main non-GI risk that can show up later. Rapid weight loss on its own raises the odds of gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), so steady, gradual loss is the safer path. Watch for upper-right abdominal pain, fever, or yellowing skin and report it (Mayo Clinic).
One emerging concern is muscle loss. Roughly 25% to 30% of total weight lost on Zepbound is lean mass, which is similar to weight loss from diet alone but higher than what some patients expect. Protein intake above 1.0 to 1.2 g/kg of goal body weight and consistent resistance training during dose escalation are the most effective countermeasures. For a deeper look at long-term GLP-1 safety, see our GLP-1 long-term risks guide and the tirzepatide side effects overview.
Zepbound side effects by dose
Side effects climb with the dose, especially the stomach ones. The table below shows how often each reaction showed up in Zepbound's pivotal obesity trials, by dose, against placebo. Most nausea and vomiting happened while moving up to a new dose and eased over time.
Stomach side effects as a whole hit about 56% of people at every dose, versus 30% on placebo, but only a small share quit because of them: 1.9% at 5 mg, 3.3% at 10 mg, and 4.3% at 15 mg, compared with 0.5% on placebo. Slower titration is the main lever for keeping these manageable.
Who should not take Zepbound (contraindications)
Zepbound carries a boxed warning. In animals, tirzepatide caused thyroid C-cell tumors, and whether that risk carries to people is unknown. Because of this, some people should not take it at all.
Do not use Zepbound if you have:
- A personal or family history of medullary thyroid carcinoma (MTC).
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- A known serious allergy to tirzepatide or any ingredient in it (serious reactions including anaphylaxis have been reported).
Use caution, and talk to your prescriber first, if you are pregnant or planning to be (Zepbound should be stopped during pregnancy), have severe stomach-emptying problems (gastroparesis), or have a history of pancreatitis or gallbladder disease. Watch for symptoms of a thyroid tumor such as a neck lump, trouble swallowing, shortness of breath, or lasting hoarseness, and report them.
Gastroparesis and surgery. Zepbound works partly by slowing how fast the stomach empties, so it can worsen pre-existing gastroparesis, a condition where the stomach already empties too slowly. That same slowing is why food or liquid can stay in the stomach before a procedure. Tell any surgical or anesthesia team that you take Zepbound well before planned surgery, an endoscopy, or deep sedation, because retained stomach contents raise the risk of aspiration into the lungs. Your care team decides whether to pause the medication first. See the Lilly Zepbound safety information.
Zepbound side effects after stopping
The main thing that happens when you stop is that the appetite comes back, and so does the weight, for most people. There is no classic chemical withdrawal, but the drug's effect fades within weeks, and the food noise it quieted tends to return.
The clearest evidence is the SURMOUNT-4 trial. After 36 weeks on Zepbound, people had lost about 21% of their body weight. Those who kept taking it lost a little more, while those switched to placebo regained about 14% of their body weight over the next year, a roughly 19 percentage-point swing. Real-world data echoes this: a 2026 Cleveland Clinic study found roughly 55% of people treated for obesity regained weight in the year after stopping. This is why clinicians describe obesity as a chronic condition that usually needs ongoing treatment, not a short course. If you plan to stop, talk to your prescriber about a maintenance dose or a transition plan rather than quitting cold.
Frequently Asked Questions
References
- U.S. FDA. Zepbound (tirzepatide) prescribing information. accessdata.fda.gov
- Eli Lilly. Managing possible side effects with Zepbound. zepbound.lilly.com
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022. PubMed
- SURMOUNT-4: Tirzepatide weight maintenance after withdrawal. JAMA. 2024. jamanetwork.com
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for Obesity (SURMOUNT-5). NEJM. 2025. PubMed
- Mayo Clinic. Tirzepatide (subcutaneous route), description and side effects. mayoclinic.org
- Cleveland Clinic. Tirzepatide injection, uses and side effects. clevelandclinic.org
- Cleveland Clinic Newsroom. What happens when patients stop taking GLP-1 drugs (2026). clevelandclinic.org
- MedlinePlus. Tirzepatide Injection. medlineplus.gov
- DailyMed (NLM). Zepbound (tirzepatide) label. dailymed.nlm.nih.gov
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Zepbound is a prescription medication with potential risks and interactions. Always follow your prescriber’s instructions and seek urgent care for severe symptoms.